These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15754409)

  • 61. Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells.
    Lenert P; Rasmussen W; Ashman RF; Ballas ZK
    DNA Cell Biol; 2003 Oct; 22(10):621-31. PubMed ID: 14611683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
    Zhao L; Wang WJ; Zhang JN; Zhang XY
    Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of azithromycin and Chlorella vulgaris treatment on certain cytokine values and NK cell activity in an acute murine toxoplasmosis model].
    Çelik Payçu DG; Büyükbaba Boral Ö
    Mikrobiyol Bul; 2017 Jan; 51(1):52-61. PubMed ID: 28283010
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
    Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y
    Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.
    Heckelsmiller K; Rall K; Beck S; Schlamp A; Seiderer J; Jahrsdörfer B; Krug A; Rothenfusser S; Endres S; Hartmann G
    J Immunol; 2002 Oct; 169(7):3892-9. PubMed ID: 12244187
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.
    Behm B; Di Fazio P; Michl P; Neureiter D; Kemmerling R; Hahn EG; Strobel D; Gress T; Schuppan D; Wissniowski TT
    Gut; 2016 Jan; 65(1):134-43. PubMed ID: 25524262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-hepatoma activity in mice of a polysaccharide from the rhizome of Anemone raddeana.
    Liu Y; Li Y; Yang W; Zhang L; Cao G
    Int J Biol Macromol; 2012 Apr; 50(3):632-6. PubMed ID: 22301002
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic Injection of a C-Type CpG ODN Induced an Antitumor Immune Response in C57/BL6 Mice of Orthotopically Transplanted Hepatocellular Carcinoma.
    Jia H; Zhao T; Zou D; Jia X; Gao J; Song X
    Oncol Res; 2016; 23(6):321-6. PubMed ID: 27131318
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
    Guo C; Liu QG; Yang W; Yao YM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides.
    Kawarada Y; Ganss R; Garbi N; Sacher T; Arnold B; Hämmerling GJ
    J Immunol; 2001 Nov; 167(9):5247-53. PubMed ID: 11673539
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
    Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
    Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effects of subcutaneous and intraocular administration of class B ODN CpG in chicken on the expression of TLR21, IFN-γ and IL-1β.
    Chrząstek K; Wieliczko A
    Pol J Vet Sci; 2014; 17(4):593-9. PubMed ID: 25638972
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses.
    Whitmore MM; Li S; Falo L; Huang L
    Cancer Immunol Immunother; 2001 Dec; 50(10):503-14. PubMed ID: 11776372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU.
    Hou S; Kou G; Fan X; Wang H; Qian W; Zhang D; Li B; Dai J; Zhao J; Ma J; Li J; Lin B; Wu M; Guo Y
    Cancer Immunol Immunother; 2007 Oct; 56(10):1605-13. PubMed ID: 17361437
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step.
    Macfarlane DE; Manzel L; Krieg AM
    Immunology; 1997 Aug; 91(4):586-93. PubMed ID: 9378499
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of Ciji Hua'ai Baosheng granule formula (CHBGF) on life time, pathology, peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells.
    Xi S; Hong R; Huang J; Lu D; Qian L; Li P; Wen L; Wang Y
    Afr J Tradit Complement Altern Med; 2014; 11(4):94-100. PubMed ID: 25392588
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.
    Schettini J; Kidiyoor A; Besmer DM; Tinder TL; Roy LD; Lustgarten J; Gendler SJ; Mukherjee P
    Cancer Immunol Immunother; 2012 Nov; 61(11):2055-65. PubMed ID: 22543528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.